[Human amniotic fluid research. In vitro antineoplastic activity].
D000230:Adenocarcinoma / Q000188:drug therapy; D000653:Amniotic Fluid / Q000502:physiology*; D000970:Antineoplastic Agents / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000037:antagonists & inhibitors; D004353:Drug Evaluation, Preclinical; D005260:Female; D008175:Lung Neoplasms / Q000188:drug therapy; D010053:Ovary / Q000187:drug effects; D013274:Stomach Neoplasms / Q000188:drug therapy; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin
Ricerche sul liquido amniotico umano. Attività antineoplastica "in vitro".